Open Access
RETRACTION
Retraction Notice to: LncRNA TUG1 Targets miR-222-3p to Take Part in Proliferation and Invasion of Breast Cancer Cells
Department of Cardiothoracic and Breast Surgery, The Second Affiliated Hospital of Chengdu Medical College, National Nuclear Corporation 416 Hospital, Chengdu, 610051, China
Oncologie 2021, 23(4), 609-609. https://doi.org/10.32604/oncologie.2021.020379
Issue published 31 December 2021
Abstract
This article has no abstract.The published article titled “LncRNA TUG1 Targets miR-222-3p to Take Part in Proliferation and Invasion of Breast Cancer Cells”, has been retracted from journal Oncologie, Vol. 22, No. 3, 2020, pp. 179–188.
DOI: 10.32604/Oncologie.2020.012544
URL: https://www.techscience.com/oncologie/v22n3/40583/pdf
The authors Xie et al. declare that due to the following reasons, they have to retract the published article from Oncologie:
1. Some experiments were not fully participated by themselves. The experimental design was unreasonable, and there were some doubts about the accuracy of the conclusions of the article.
2. The experiment needs to be further improved, and some data also need to be verified again.
After a comprehensive verification, in order to ensure the authenticity of the data and minimize the negative impact on readers, Tech Science Press has decided to accept the request for Retraction. The authors apologize for the Retraction and assume full responsibility for the consequences of what the Retraction has caused.
Tech Science Press is fully committed to enforcing strict ethical policies and following the COPE Retraction Guidelines. The essential condition of submitting a manuscript for publication in Oncologie is that authors must explicitly declare that their works are original and have not been previously published elsewhere. Reuse of any data should be appropriately cited. To set the record straight, we hereby announce the Retraction of the paper, and would like to sincerely apologize to our readers for any inconvenience this may have caused.
Cite This Article
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.